Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
25-40% of hypertension patients require only monotherapy to control BP, so choice of right single therapeutic agent is critical.
Read More »Most Effective Hypertensive Medications that Prevent Nephropathy in Diabetic Patients
Dr. George Bakris Part 2, BP In Patients with Microalbuminuria
In part 2 of this exclusive video, DIC publisher Steve Freed once again visits with Dr. George Bakris to discuss causes of microalbuminuria (small amounts of albumin in the urine) and blood pressure recommendations for patients with microalbuminuria.
Read More »The Association Between Uric Acid Levels and Chronic Kidney Disease (CKD)
Can high uric acid levels be an indicator of changes in kidney function?
Read More »Shocking Increase in Adolescent Diabetes Complications
Diabetic nephropathy risk found on rise in 12- to 18-year-old patients.
Read More »Patients with Prediabetes at Risk for Early Kidney Damage
Research study finds high levels of glucose could be affecting kidneys even prior to diabetes diagnosis.
Read More »Dr. Richard Bergman, Part 4 – Diabetes, Altitude and the Role of Kidneys in Research
Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman discuss his ADA presentations — the relationship between diabetes and altitude, and the role of kidneys in diabetes research. Steve also asks why the degredation of insulin in the liver is important in the pathogenesis of diabetes. Dr. Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.
Read More »Mortality Among Persons with Type 2 Diabetes
Risks of death varied depending on age, glycemic control and renal complications.
Read More »Biomarkers of Major Adverse Outcomes in Diabetes
Recent study suggests that compelling biomarkers may predict major adverse outcomes, including death, in diabetes.
Read More »Finerenone Improves Albuminuria in Diabetic Nephropathy Patients
Mineralocorticoid receptor antagonists (MRAs) are often used with a renin-angiotensin system (RAS) blocker to further reduce proteinuria in patients with CKD. However, eplerenone and spironolactone increase the risk of hyperkalemia in these patients. Finerenone (BAY94-8862) is a new nonsteroidal MRA that has better receptor selectivity than spironolactone, associating with lower …
Read More »The Relationship Between Renal and Retinal Disorder in Type 2 Diabetes
Researchers study retinopathy as possible indicator of nephropathy… The number of diabetes mellitus cases is on the rise while the incidence of end-stage kidney disease from diabetes has decreased over the years. However, diabetes remains the main cause of end-stage kidney disease in the United States and other countries. There …
Read More »